Drug Type Proteolysis-targeting chimeras (PROTAC) |
Synonyms- |
Target |
Mechanism c-Kit inhibitors(Stem cell growth factor receptor inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC35H35FN6O6 |
InChIKeyVXBLUAKQWQJPAD-QJOMJCCJSA-N |
CAS Registry2222635-92-7 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Leukemia | Preclinical | US | 22 Jan 2018 | |
Leukemia | Preclinical | US | 22 Jan 2018 |